- Home
- IPGP vs CPRX Comparison
IPGP vs CPRX Comparison
Compare IPGP & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPGP
- CPRX
- Stock Information
- Founded
- IPGP 1990
- CPRX 2002
- Country
- IPGP United States
- CPRX United States
- Employees
- IPGP N/A
- CPRX N/A
- Industry
- IPGP Semiconductors
- CPRX Biotechnology: Pharmaceutical Preparations
- Sector
- IPGP Technology
- CPRX Health Care
- Exchange
- IPGP Nasdaq
- CPRX Nasdaq
- Market Cap
- IPGP 3.2B
- CPRX 2.6B
- IPO Year
- IPGP 2006
- CPRX 2006
- Fundamental
- Price
- IPGP $86.37
- CPRX $21.01
- Analyst Decision
- IPGP Buy
- CPRX Strong Buy
- Analyst Count
- IPGP 7
- CPRX 5
- Target Price
- IPGP $77.60
- CPRX $33.20
- AVG Volume (30 Days)
- IPGP 206.4K
- CPRX 1.1M
- Earning Date
- IPGP 11-04-2025
- CPRX 11-05-2025
- Dividend Yield
- IPGP N/A
- CPRX N/A
- EPS Growth
- IPGP N/A
- CPRX 183.96
- EPS
- IPGP N/A
- CPRX 1.65
- Revenue
- IPGP $945,994,000.00
- CPRX $558,499,000.00
- Revenue This Year
- IPGP $0.28
- CPRX $16.59
- Revenue Next Year
- IPGP $7.47
- CPRX $8.80
- P/E Ratio
- IPGP N/A
- CPRX $12.75
- Revenue Growth
- IPGP N/A
- CPRX 28.55
- 52 Week Low
- IPGP $48.59
- CPRX $19.05
- 52 Week High
- IPGP $90.30
- CPRX $26.58
- Technical
- Relative Strength Index (RSI)
- IPGP 54.33
- CPRX 53.55
- Support Level
- IPGP $84.52
- CPRX $20.66
- Resistance Level
- IPGP $88.80
- CPRX $21.52
- Average True Range (ATR)
- IPGP 3.19
- CPRX 0.55
- MACD
- IPGP -0.02
- CPRX 0.04
- Stochastic Oscillator
- IPGP 63.33
- CPRX 67.27
About IPGP IPG Photonics Corporation
IPG Photonics Corp is a vertically integrated developer and manufacturer of high-performance fiber lasers, fiber amplifiers, and diode lasers, which are used in diverse applications in the manufacturing, automotive, industrial, aerospace, semiconductor, and consumer end markets. The company operates in one segment which involves the design, development, production and distribution of fiber lasers, laser and non-laser systems, fiber amplifiers, and related optical components. A large majority of the firm's revenue is derived from materials processing applications for fiber lasers, including cutting and welding, marking and engraving, and micro-processing. The company generates a majority of its revenue from North America and also has its presence in China, Japan, Germany, and other markets.
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).